Different gonadotropin and leuprorelin ovulation induction regimens markedly affect follicular fluid hormone levels and folliculogenesis

What Was Tested

Researchers studied HMG (Human Menopausal Gonadotropin) and Leuprolide in this randomized controlled trial publication.

To clarify the endocrine mechanisms underlying the outcome of different ovulation induction regimens with gonadotropins and GnRH agonists (GnRH-a).

Who Took Part

According to the abstract, 10 subjects were involved.

The age groups tagged for this paper are adults, women only.

Forty eumenorrheic women randomly assigned to four groups of 10 subjects each.

Ovulation induction regimens: group A, purified FSH only; group B, purified FSH and flare-up GnRH-a; group C, purified FSH and long GnRH-a; and group D, hMG and long GnRH-a.

How the Study Was Run

In design terms this was a randomized study.

The subjects were allocated by chance, so the HMG (Human Menopausal Gonadotropin) group and the comparison group should start out alike.

Reproductive Endocrinology Center, University of Bologna.

What Was Measured

PubMed files the paper under topics including Fertility Agents, Female, Follicle Stimulating Hormone, Follicular Fluid, Gonadal Steroid Hormones, Gonadotropins, Leuprolide and Menotropins.

What This Means in Plain Language

The paper is a randomized study of HMG (Human Menopausal Gonadotropin) and Leuprolide in 10 subjects.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The abstract goes on to report its results in about 8 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 1996 (Fertility and sterility), a journal based in United States.

More context: the HMG (Human Menopausal Gonadotropin) compound page and the Leuprolide compound page, all human trials.